Biblio

2021
Xu X, Nie Y, Wang W, Ullah I, Tung WTai, Ma N, Lendlein A. Generation of 2.5D lung bud organoid from human induced pluripotent stem cell. Clin Hemorheol Microcirc. 2021.
Cutts J, Kostes W, Brafman DA. Generation of 3X FLAG-tagged human embryonic stem cell (hESC) line to study WNT-induced β-catenin DNA interactions (HVRDe009-A-2). Stem Cell Res. 2021;57:102586.
Lee O-H, Lee S, Park M, Moon S, Hwang S, Kim B, Kim C-Y, Lee DRyul, Shim SHan, Park K-H, et al. Generation of a B2M homozygous knockout human somatic cell nuclear transfer-derived embryonic stem cell line using the CRISPR/Cas9 system. Stem Cell Res. 2021;59:102643.
Zhou Z, Yoshimatsu S, Qian E, Ishikawa M, Sato T, Ohtaka M, Nakanishi M, Okano H. Generation of a control human induced pluripotent stem cell line using the defective and persistent Sendai virus vector system. Stem Cell Res. 2021;56:102549.
Graffmann N, Martins S, Ljubikj T, Matte JCarole, Bohndorf M, Wruck W, Adjaye J. Generation of a Crigler-Najjar Syndrome Type I patient-derived induced pluripotent stem cell line CNS705 (HHUUKDi005-A). Stem Cell Res. 2021;51:102167.
Li T, Ma B, Yang H, Zhu G, Shu C, Luo M, Zhou Z. Generation of a CRISPR/Cas9-corrected-hiPSC (NCCDFWi001-A-1) from a Marfan syndrome patient hiPSC with a heterozygous c.2613A>C variant in the fibrillin 1 (FBN1) gene. Stem Cell Res. 2021;56:102543.
Zhang W, Li Y, Wang L, Xin T, Zhang C. Generation of a DKK2 homozygous knockout human embryonic stem cell line using the CRISPR/Cas9 system. Stem Cell Res. 2021;57:102611.
Angulo MBurgos, Yang J, Argenziano MA, Bertalovitz AC, Beidokhti MNajari, McDonald TV. Generation of a Friedreich's Ataxia patient-derived iPSC line USFi001-A. Stem Cell Res. 2021;54:102399.
Gao X, Qiu S-W, Wang W-Q, Kang D-Y, Su N, Dai P, Yuan Y-Y. Generation of a gene corrected human isogenic iPSC line (CPGHi002-A-1) from a DDOD patient with heterozygous c.1516 C>T mutation in the ATP6V1B2 gene. Stem Cell Res. 2021;53:102271.
Sun X, Zhou X, Dong B, Wang C, Xiao X, Wang Y. Generation of a gene-corrected isogenic iPSC line (AHQUi001-A-1) from a patient with familial hypertriglyceridemia (FHTG) carrying a heterozygous p.C310R (c.928 T > C) mutation in LPL gene using CRISPR/Cas9. Stem Cell Res. 2021;52:102230.
Lilianty J, Bateman JF, Lamandé SR. Generation of a heterozygous COL2A1 (p.G1113C) hypochondrogenesis mutation iPSC line, MCRIi019-A-7, using CRISPR/Cas9 gene editing. Stem Cell Res. 2021;56:102515.
Huang S, Fu W, Guo G, Tiana X, Zhao X, Dong J, Li X, Yang H. Generation of a hiPSC line ZZUNEUi017-A from a patient with dilated cardiomyopathy caused by mutation in TTN. Stem Cell Res. 2021;52:102248.
Romano E, Trionfini P, Giampietro R, Benigni A, Tomasoni S. Generation of a homozygous CIITA knockout iPS cell line using the CRISPR-Cas9 system. Stem Cell Res. 2021;57:102580.
Hang C, Song Y, Wu F, Dong T, Jiang M, Saleem A, Zhang S, Chang Y, Lu W, Cui M. Generation of a homozygous COX6A2 knockout human embryonic stem cell line (WAe009-A-47) via an epiCRISPR/Cas9 system. Stem Cell Res. 2021;50:102152.
San Huang P-, Wen M-H, Xie X, Xu A, Lee D-F, Chen T-Y. Generation of a homozygous knock-in human embryonic stem cell line expressing SNAP-tagged SOD1. Stem Cell Res. 2021;54:102415.
You J, Cheng Y, Yang X-J, Chen L. Generation of a homozygous LRP2 knockout human embryonic stem cell line (FDCHDPe010-A-56) by CRISPR/Cas9 system. Stem Cell Res. 2021;53:102342.
You J, Xi H, Ma S, Yang X-J, Chen L. Generation of a homozygous LRPAP1 knockout human embryonic stem cell line (FDCHDPe009-B) by CRISPR/Cas9 system. Stem Cell Res. 2021;56:102516.
Chen D, Song B, Cheng Y, Zhu L, Lu D, Liu N, Yang Y, Sun X. Generation of a homozygous ZBTB7A knockout human induced pluripotent stem line by CRISPR/Cas9 editing. Stem Cell Res. 2021;55:102494.
Wu S, Zhu T, Sun Z, Wei X, Han X, Zou X, Sui R. Generation of a human induced pluripotent stem cell line from a Bietti crystalline corneoretinal dystrophy patient with CYP4V2 mutations. Stem Cell Res. 2021;53:102330.
Zhang W, Hua Y, Di W, Guo J, Dai Q, Zhao J, Zhang B, Wang Y. Generation of a human induced pluripotent stem cell line (SIAISi011-A) from a 61-year-old Chinese Han healthy female donor. Stem Cell Res. 2021;51:102173.
Yan R, Wu S, Wang W, Chu M, Liu P. Generation of a human induced pluripotent stem cell line (SMUSHi001-A) from a patient with 46, XX male sex reversal syndrome carrying the SRY gene. Stem Cell Res. 2021;54:102397.
Guo X, Qian R, Shan X, Yang L, Chen H, Ding Y, Chen C, Chu M, Lin J, Wang D. Generation of a human induced pluripotent stem cell line (WMUi021-A) from a Gitelman syndrome patient carrying a SLC12A3 gene mutation (c.179C > T). Stem Cell Res. 2021;53:102280.
Lee S-H, Oh J, Lee S-T, Won D, Kim S, Choi H-K, Kim S-J, Han H, Yoon M, Choi JRak, et al. Generation of a human induced pluripotent stem cell line YCMi004-A from a patient with dilated cardiomyopathy carrying a protein-truncating mutation of the Titin gene and its differentiation towards cardiomyocytes. Stem Cell Res. 2021;59:102629.
Ge W, Song Y, Chu M, Liu Y, Yang B, Wang K, Yu B, Song C, Wang Y, Yang J. Generation of a human iPSC line CIBi009-A from a patient with familial hypercholesterolemia carrying variants of LDLR c.T1241G and APOB c.G1618T. Stem Cell Res. 2021;53:102347.
Wu S, Zhang Z, Wang L, Yu J. Generation of a human iPSC line QDMHi001-A from a patient with Marfan syndrome carrying a heterozygous c.6772 T > C variant in FBN1. Stem Cell Res. 2021;54:102390.

Pages